Relationship between preexisting anti-varicella-zoster virus (VZV) antibody and clinical VZV reactivation in hematopoietic stem cell transplantation recipients

Journal of Clinical Microbiology

Volumn 44, Issue 12, 2006, Pages 4441-4443

  Onozawa, Masahiro ^a   Hashino, Satoshi ^a   Takahata, Mutsumi ^a   Fujisawa, Fumie ^a   Kawamura, Takahito ^a   Nakagawa, Masao ^a   Kahata, Kaoru ^a   Kondo, Takeshi ^a   Ota, Shuichi ^a   Tanaka, Junji ^a   Imamura, Masahiro ^a   Asaka, Masahiro ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; HERPES ZOSTER IMMUNOGLOBULIN; IMMUNOGLOBULIN; VIRUS DNA;

ADOLESCENT; ADULT; AGED; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE COURSE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPES ZOSTER; HUMAN; IMMUNE ADHERENCE; MALE; NONHUMAN; OPPORTUNISTIC INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VARICELLA ZOSTER VIRUS; VIRUS LOAD; VIRUS REACTIVATION;

ADULT; AGED; ANTIBODIES, VIRAL; DNA, VIRAL; FEMALE; HEMATOLOGIC DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNE ADHERENCE REACTION; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; STATISTICS; VIRAL LOAD; VIRUS ACTIVATION;

HUMAN HERPESVIRUS 3;

EID: 33845582368     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01312-06     Document Type: Article

References (10)

1. Arvin, A. M. 2000. Varicella-zoster virus: pathogenesis, immunity, and clinical management in hematopoietic cell transplant recipients. Biol. Blood Marrow Transplant. 6:219-230.
2. Arvin, A. M. 2001. Varicella-zoster virus, p. 2731-2767. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 4th ed. Lippincott-Raven Publishers, Philadelphia, Pa.
3. Centers for Disease Control and Prevention. 2004. CDC guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Morbid. Mortal. Wkly. Rep. 49:RR-10.
4. Han, C. S., W. Miller, R. Haake, and D. Weisdorf. 1994. Varicella-zoster infection after bone marrow transplantation: incidence, risk factors and complications. Bone Marrow Transplant. 13:277-283.
5. Kalter, Z. G., S. Steinberg, and A. A. Gershon. 1997. Immune adherence hemagglutination: further observations on demonstration of antibody to varicella-zoster virus. J. Infect. Dis. 135:1010-1013.
6. Leung, T. F., K. W. Chik, C. K. Li, M. M. K. Shing, P. K. S. Chan, V. Lee, and P. M. P. Yuen. 2000. Incidence, risk factors and outcome of varicella-zoster virus infection in children after hematopoietic stem cell transplantation. Bone Marrow Transplant. 25:167-172.
7. Mazur, M. H., R. J. Whitley, and R. Dolin. 1979. Serum antibody levels as risk factors in the dissemination of herpes zoster. Arch. Intern. Med. 139:1341-1345.
8. Takahashi, M. 2004. Effectiveness of live varicella vaccine. Expert Opin. Biol. Ther. 4:199-216.
9. Wacker, P., O. Hartmann, E. Benhamou, E. Salloum, and J. Iemerle. 1989. Varicella-zoster virus infections after autologous bone marrow transplantation in children. Bone Marrow Transplant. 4:191-194.
10. Zaia, J. A., M. J. Levin, S. R. Preblud, et al. 1983. Evaluation of varicella-zoster immune globulin: protection of immunosuppressed children after household exposure to varicella. J. Infect. Dis. 149:737-743.